ArticleCancer biology & therapy2013

Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy.

Nichola Cruickshanks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.